Streptomycin-loaded PLGA-alginate nanoparticles: preparation, characterization, and assessment by Asadollah Asadi
ORIGINAL ARTICLE
Streptomycin-loaded PLGA-alginate nanoparticles: preparation,
characterization, and assessment
Asadollah Asadi
Received: 20 February 2013 / Accepted: 27 March 2013 / Published online: 17 April 2013
 The Author(s) 2013. This article is published with open access at Springerlink.com
Abstract The aim of this study was to formulate and
characterize streptomycin-loaded PLGA-alginate nanopar-
ticles for their potential therapeutic use in Salmonella
subsp. enterica ATCC 14028 infections. The streptomycin
nanoparticle was prepared by solvent diffusion method,
and the other properties such as size, zeta potential, loading
efficacy, release kinetics, and antimicrobial strength were
evaluated. The survey shows that nanoparticles may serve
as a carrier of streptomycin and may provide localized
antibacterial activity in the treatment of Salmonellosis.
Electron microscopy showed spherical particles with
indentations. The average size of the nanoparticles was
90 nm. At pH 7.2, the release kinetics of streptomycin from
the nanoparticles was successfully illustrated as an initial
burst defined by a first order equation that after this stage, it
has a drastic tendency to obtain steady state. Nevertheless,
nanoparticles showed loading efficacy nearly about
70–75 %. In addition, the tendency of concentration of
streptomycin released from nanoparticles to reach anti-
bacterial activity was similar to that of free streptomycin
against PLGA-alginate, but it had threefold more antimi-
crobial strength in comparison with free streptomycin. This
work shows the potential use of streptomycin-loaded
PLGA-alginate nanoparticles and its capability.
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Introduction
Today, nanotechnology plays an important role in the
most of research fields such as medicine, biology, and so
on. One of the most crucial issues is drug delivery sys-
tems. In these systems, drugs have been delivered by a
carrier with out any interaction between drug and capsule.
These carriers are new vehicles which can cause deliver
encapsulant to their right and appropriate place. Also,
these systems allow protection of sensitive ingredient
from unwanted reaction that lead to structural changes
and emerging unpleasant taste or odor (Zohri et al. 2010).
Another benefit of these systems is the control release
property that can increases functional properties of food.
Among different drug delivery systems, polymeric nano-
particles are good candidate for drug delivery due to their
unique properties such as good stability, suitable size, and
appropriately drug release (Slu¨tter et al. 2010). Also
between various carriers proposed, biodegradable nano-
particles poly(lactide-co-glycolide) are well established to
have high delivery potential of manifold drugs such as
alginate and chitosan that are two worthwhile polymeric
materials in this area due to low cost and compatibility
for vast board of materials. Also they are certified by
FDA and are safe (Fathi et al. 2012). One of the most
studied polymers for drug delivery is undoubtedly the
poly(lactic-co-glycolic acid) (PLGA) and alginate (deriv-
atives). These polymers have some features such as
safety, biodegradability, and compact ability. PLGA has
been used for controlled drug release purposes since many
years ago, and it is also a suitable choice for encapsula-
tion of antimicrobial compounds (Manca et al. 2008).
Furthermore, PLGA particles are prepared by various
methods; oil-in-water emulsification or solvent evapora-
tion techniques, generally resulting in negatively charged,
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smooth surfaced, and spherical particles (Witschi and
Doelker 1998).
These particles have properties such as resistant to salt
and pH induced instability, and slowly releases their con-
tent based on the hydrolysis rate of the polymer (Sweet
et al. 2007). Choi et al. (2010) used PLGA and alginate
using for dual growth factor delivery system of bone
morphogenetic protein (BMP)-2 and dexamethasone.
Sweet et al. (2007) designed and developed a novel con-
trolled release of PLGA alginate-pectinate polyspheric
drug delivery system in 2007, and they demonstrated that
as the polyspheres are provided, they are flexible yet as the
superior rate-modulated drug delivery. Sivadas et al.
(2008) demonstrated that a range of polymeric micro-
spheres as potential carriers for the inhalation of proteins
showed particular promise for specific protein delivery
needed in the lungs.
There has been dramatically concern in recent years
against the food-borne pathogen of human. Of the patho-
gens, there are crucial issues such as salmonella species
food-borne infections constitute a significant cause of
morbidity and mortality in human populations and infec-
tions caused by enterica, in particular (Zottola et al. 2012).
Streptomycin is an antibiotic medicine, which is com-
posed of a metabolic product of Streptomyces globisporus
streptomycin or another similar organism (Mashkovskii
1998). It is effective against a spectra range of bacteria and
is particularly used in the treatment of tuberculosis. The
major disadvantages of streptomycin are inadequate pene-
tration into the cells due to its hydrophilicity, rapid elimi-
nation due to both efficient renal filtration, and low level of
association to plasma proteins (Coessens et al. 1996).
Nurkeeva et al. (2004) produced a polycomplexes of
poly(acrylic acid) with streptomycin sulfate in 2003 and
evaluated their antibacterial activity using Sarcina sp. as a
model organism, and they demonstrated that the poly-
complexes have an antimicrobial activity on the same level
as the free drug.
Doran et al. (2006) studied interpreting streptomycin
susceptibility test results for Salmonella enterica serovar
Typhimurium, and they found S. enterica serovar
Typhimurium presenting appropriate interpretive criteria.
Hoffman et al. (1949) reported the synthesis of a mac-
romolecular streptomycin derivative to optimize its phar-
macokinetics. They attached streptomycin to methacrylic
acid hydroxide and the final product was copolymerized
with methacrylamide (Hoffman et al. 1949). This resulted
in a non-degradable vinyl type copolymer carrier. The
hydrolytic stability of the polymer-streptomycin conjugate
was studied at physiological and lysosomal pH (pH 7.4 and
5.2, respectively). Streptomycin release was found to be
faster in the lysosomal pH range. Despite the fact that
streptomycin is an effective antimicrobial agent, there are
effective factors that are mentioned before its antimicrobial
potentiality might decrease, so most of the researchers also
tired to keep its properties and use from their antimicrobial
properties. The mentioned researchers certified that drug
delivery systems were effective somewhat, but with con-
sidering type of polymers and ratio of them in formulation
and even amount of encapsulant, it can be concluded that
manifold products must be characterized and evaluated. In
this research, new combination of streptomycin with PLGA
were produced and studied.
Materials and methods
Materials include streptomycin sulfate salt, poly(D,L-lac-
tide-co-glycolide) lactide:glycolide (50:50), mol wt
30,000–60,000, sodium alginate from Sigma-Aldrich Co
was purchased. Dialysis membrane bag, 10 KD, was pur-
chased from Spectrum Lab, USA and Salmonella subsp.
enterica ATCC 14028 from Persian collection were pre-
pared from Persian collection of bacteria in Iranian
Research Organization for Science and Technology.
Method of producing the streptomycin-loaded PLGA/
alginate nanoparticles
PLGA nanoparticles were prepared by a solvent diffusion
method on the basis of Wang et al. (2011) with few
modifications. Totally, 100 ll of streptomycin solution
(100 mg/ml) was added drop-wise to alginate solution and
stirred for 30 min. Then 100 mg of PLGA was added into
alginate (dissolved in deionized water) surfactant solution
with different concentrations (0.1, 0.2, 0.5, and 1.0 %)
through a syringe pump at constant rate (20, 40, and
60 ml/h) under stirring at 200 rpm, and then nanoparticles
were collected by centrifugation (Beckman Co., Avanti 30)
(14,000 rpm, 15 min). The nanoparticles were resuspended
using deionized water and centrifuged thrice to remove
excess alginate. A fine powder of charged nanoparticles
was obtained by lyophilization for 2 days.
Morphology of the nanoparticles
Scanning electron microscopy was used for shape and
occurrence of aggregation phenomena evaluation. Prior to
observation, 10 ll of the sample of nanoparticle suspen-
sions were mounted on metal stub plating coated under
vacuum and then for more investigation examined by
scanning electron microscopy (FWH-1200A, 500 V, UK).
All formulations were evaluated with scanning microscopy
and formation of nanoparticles was assessed.
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Size and zeta potential of the nanoparticles
Zetasizer 3000 HS (Malvern Instruments, UK) evaluated
the size and surface zeta potential of the nanoparticles.
Each sample was diluted (1:1) with 10 diluted aqueous
dispersion of the nanoparticles prepared from the three
polymer ratios and measured by the device in triplicate
(Blanco and Alonso 1998).
Determination of loading efficiency of the nanoparticles
For this assessment, streptomycin-loaded nanoparticles
dispersions were centrifuged using a 100-kDa molecular
weight cut off ultrafilter (Amicon Ultra-15 Ultracel-100 K)
at 15,0009g, 25 C for 10 min. Then, the streptomycin
loading efficiency (LE) was calculated using Eq. 1 (Zohri
et al. 2011):
LE %ð Þ ¼ StreptomycinTotal
 StreptomycinSupernatant=StreptomycinTotal
ð1Þ
Release assessment of streptomycin
from the nanoparticles
Release of streptomycin was counted by dialysis method.
First of all, the 10 kDa (MWCO) membrane was selected
as the MWCO was large enough to allow passage strep-
tomycin to pass. For the experiment, 5 ml of a 10-mg/ml
solution of phosphate-buffered saline (PBS) at pH 7.4
(release media) was poured into the inner tube of the dia-
lyzer. The dialyzer tube was placed into a 100 ml glass
cylinder containing release media, which was continually
stirred at 300 rpm using a small magnetic stir bar to pre-
vent the formation of an unstirred water layer at the
membrane/outer solution interface. Diffusion to the outer
solution at 37 C was assessed by sampling the contents of
the outer solution at periodic intervals of 0, 10.20, 40,
60.80, 100, 120, 150, 180, 200 (Zohri et al. 2011).
Sensitivity test against salmonella
Salmonella subsp. enterica ATCC 14028 was prepared
from PTCC (Persian Type Culture Collection). Culture
methods consist of inoculating 1 ml of stock into 100 ml of
tetrathionate broth and incubating at 37 C for 48 h, sub-
culturing 10 ml of the tetrathionate broth into 100 ml RV
broth, and incubating at 37 C for 24 h, then inoculating
XLT4 agar plates with 10 ml of the RV broth and incu-
bating 24 h at 37 C before screening for suspect Salmo-
nella colonies. Also the microbial count for three samples
as control sample which include salmonella and the
sample that includes free streptomycin ? Salmonella and
nanoparticle ? Salmonella in three replicate (Nurkeeva
et al. 2004).
Testing of antibacterial activity using agar well
diffusion method
Resistant bacterial strains were inoculated into 10 ml of
sterile nutrient broth, and incubated at 37 C for 8 h. Each
culture was swabbed on the surface of sterile nutrient agar
plate in duplicate. In each agar plate of both sets, four wells
were prepared with the help of sterilized cork borer of
10 mm diameter on the basis of Palashka method (Palaksha
et al. 2010). In the wells of first plate of each set, 100 ll
test samples of following concentrations: (1) standard
streptomycin 10 mg/ml in sterile distilled water, (2)
streptomycin-loaded nanoparticles (5 %), (3) streptomy-
cin-loaded nanoparticles (2 %), (4) streptomycin-loaded
nanoparticles (1 %) were added using micropipette. Every
plate used according to the aforementioned procedure was
performed in triplicate for statistical average.
Statistical analysis
All of the experiments were done in triplicates and the
averages of the data were compared with independent




The morphology of the nanoparticles was analyzed by
transmission electron microscopy (Fig. 1) and it was
illustrated that the particles were separate, spherical with in
the size ranging from 55 to 98 nm. The results of similar
research had agreement with other researcher results
(Slu¨tter et al. 2010; Witschi and Doelker 1998). Results
also showed that from four concentrations 0.5 % due to
electrostatic stability and charge, balance was stable and
observable under microscope (Zohri et al. 2010). In for-
mulations 0.1, 0.2 and 1 % concentrations, nanoparticles
were not formed or were not stable for observation under
SEM. Figure 2 show scanning electron microscope for
0.5 % ratio. So other characterizations were done for
0.5 %.
Size and zeta potential assessment
The image illustrated that the mean size of nanoparticles
were between 10 and 100 nm, and the mean of PDI
(polydispersity index) of the nanoparticles was 0.30 mv.
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PDI is the index which indicates the homogeneity of the
particles. The zeta potential of nanoparticles showed that
the nanoparticles have good stability (Fig. 1).
Release profile and loading efficiency evaluation
of the nanoparticles
Release of an entrapped protein from particle involves the
swelling and loosening of the compact structure of the
particle, allowing protein molecules entrapped at sub layers
of the particles to divorce under hydrolytic actions, and
then disperse through and come-off from the particle
structure. There are two steps in this release process, one
stage is called as burst release that include swelling of
nanoparticles specially polysaccharides which happens
0–60 min after starting of release. It was found that the
initial burst of release might be due to the degradation of
the PLGA chain (Niwa et al. 1994), and after this stage will
be release toward a steady stage for 200 min from the
initial release. Loading efficiency was determined 70–75 %
using the Eq. 1 because of good reaction and stability of
nanoparticles, Zeta potential results were also in agreement
with these results (Fig. 3).
Microbial assessment
The results showed that the samples with streptomycin-
loaded PLGA/alginate nanoparticles (5 %) had zone
diameter value C10 mm in comparison with samples with
naked streptomycin, which was about maximum 7 mm
and Streptomycin-loaded PLGA nanoparticles (2 %) and
(1 %) with zone diameter about 3 mm (Fig. 4). Microbial
count results also confirmed this (Fig. 5). Doran et al.
Fig. 1 The averages of size of the nisin-loaded chitosan/alginate
nanoparticles (SD standard deviation, n = 3)
Fig. 2 SEM image of the nisin-loaded chitosan/alginate nanoparti-
cles (5 %)
Fig. 3 Release kinetics of streptomycin from the nanoparticles at
different times
Fig. 4 Well diffused agar results for three samples: (1) standard
streptomycin 10 mg/ml in sterile distilled water, (2) streptomycin-
loaded nanoparticles (5 %), (3) streptomycin-loaded nanoparticles
(2 %), (4) streptomycin-loaded nanoparticles (1 %) as mentioned in
the text
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(2006) also determined the streptomycin MIC for isolates
of Escherichia coli with zone diameters of 11–12 mm,
and they suggested that interpretive criteria for MIC
results should be susceptible at 8 mg/l and resistant at
16 mg/l. Microbial count showed that in sample with
nanoparticles, salmonella growth was completely inhib-
ited. Maintaining streptomycin structure and helping
antimicrobial strength maintenance are of crucial impor-
tance (Doran et al. 2006). Another issue is due to syner-
gistic effects of PLGA, and it is highly affected by the
streptomycin properties and its possible interaction with
PLGA and its degradation products. The results of blanco
et al. was in agreement with this finding (Blanco and
Alonso 1998; Brenda and Rostagno 2008; Neeraj et al.
2008).
Conclusion
Interaction between streptomycin sulfate and PLGA in
aqueous solutions led to the formation of good stability
nanoparticles. The structure of the nanoparticles is com-
pact and their stability/solubility is greatly dependent on
the pH. Release of streptomycin is a pH-dependent factor
with attention to the in vitro release results, about
90–95 % release, in the medium with pH of 7.4 (because
this pH leads to the more positive charge of nisin and
consequently, more partitioning of streptomycin into the
release medium) (Zohri et al. 2010). It was shown that the
nanoparticles have the same level of antimicrobial activity
as the free drug. The information obtained in the present
work can be used for the design of new drug delivery
systems and can be also taken into account for the pre-
diction of drug interactions within pharmaceutical
formulations.
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